Proteína morfogenética ósea y su opción como tratamiento de la fisura alveolar

Uribe, Francisca; Cantín, Mario; Alister, Juan Pablo; Vilos, Cristián; Fariña, Rodrigo; Olate, Sergio.
Int. j. morphol ; 35(1): 310-318, Mar. 2017. ilus
Artigo em Espanhol | LILACS | ID: biblio-840971

Documentos relacionados

  1. Use of Bone Morphogenetic Protein in Pediatric Cranioplasty With Pre- and Postoperative Radiation Therapy.
  2. Assessment of outcome following the use of recombinant human bone morphogenetic protein-2 for spinal fusion in the elderly population.
  3. Current Trends in Recombinant Human Bone Morphogenetic Protein 2 (rhBMP2) Usage for Spinal Fusion Surgery.
  4. Applications of Bone Morphogenetic Protein-2: Alternative Therapies in Craniofacial Reconstruction.
  5. Outcomes of Alveolar Ridge Preservation With Recombinant Human Bone Morphogenetic Protein-2: A Systematic Review.
  6. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma.
  7. Evaluating the efficacy of recombinant human bone morphogenic protein-2 in the treatment of alveolar clefts with autologous bone grafting using computer-aided engineering techniques.
  8. Clinical application of recombinant human bone morphogenetic protein in cats and dogs: a review of 13 cases.
  9. Bone Morphogenetic Protein 2 Plus Leukocyte and Platelet-Rich Fibrin for the Treatment of MRONJ.
  10. Use of human recombinant bone morphogenetic protein is associated with increased hospital charges in children with cleft lip and palate having bone graft procedures.